Skip to main content

89bio, Inc.

ETNBDelisted Oct 30, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001785173

89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding 89bio, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of ETNB: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders69170+2
Shares17.1M1.23K32.5M+15.4M (+90.2%)
Value$64.3M$5.00K$104.6M+$40.2M (+62.5%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held 89bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ETNB in Q2 2022
InstitutionSharesValue% of portfolio
BVF Inc3,898,000$12.6M0.61%
Janus Henderson Group PLC1,690,140$5.45M0.00%
Great Point Partners LLC1,400,000$4.51M1.16%
Boxer Capital, LLC1,400,000$4.51M0.29%
TCG Crossover Management, LLC1,133,196$3.65M1.55%
Adage Capital Partners GP, L.L.C.1,100,000$3.54M0.01%
Deerfield Management Company, L.P. (Series C)506,100$1.63M0.03%
Sphera Funds Management Ltd.450,000$1.45M0.28%
Empery Asset Management, LP400,000$1.29M6.97%
Newtyn Management, LLC310,000$998.0K0.19%
Alyeska Investment Group, L.P.300,000$966.0K0.01%
Maven Securities LTD300,000$966.0K0.17%
Walleye Capital LLC294,950$950.0K0.03%
Laurion Capital Management LP187,100$602.0K0.03%
Marshall Wace, LLP149,542$482.0K0.00%
Invesco Ltd.123,356$397.0K0.00%
Hudson Bay Capital Management LP77,126$248.0K0.00%
Ergoteles LLC47,600$153.0K0.00%
Bailard, Inc.29,692$96.0K0.00%
Virtu Financial LLC20,222$65.0K0.01%
Raymond James & Associates19,507$63.0K0.00%
Squarepoint Ops LLC10,348$33.0K0.00%
Capital Advisors, Ltd. LLC798$3.00K0.00%
Advisor Group Holdings, Inc.282$1.00K0.00%
Credit Suisse AG5$00.00%

Sold out (23)

Institutions that held 89bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (1)

Institutions that held 89bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ETNB in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.1,226$5.00K